Reinisch M, Nusch A, Decker T, Hartkopf A, Heinrich BJ, Kurbacher CM, Fuchs R, Tesch H, Krabisch P, Brucker SY, Fehm T, Janni W, Kuemmel S, Luftner D, Schneeweiss A, Schuler M, Voges C, Schubert J, Fasching P (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: AMER ASSOC CANCER RESEARCH
City/Town: PHILADELPHIA
Conference Proceedings Title: CANCER RESEARCH
DOI: 10.1158/1538-7445.sabcs20-ps10-31
APA:
Reinisch, M., Nusch, A., Decker, T., Hartkopf, A., Heinrich, B.J., Kurbacher, C.M.,... Fasching, P. (2021). Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results. In CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
MLA:
Reinisch, Mattea, et al. "Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results." Proceedings of the CANCER RESEARCH PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2021.
BibTeX: Download